Generic vs Brand Bone Drug for Breast Cancer, Skeletal Mets Generic vs Brand Bone Drug for Breast Cancer, Skeletal Mets

Monthly denosumab more effective than zoledronic acid in delaying time to first skeletal-related events but over 2 years cost almost $350K more.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news